Company Filing History:
2 out of 512 
1 out of 711 
1 out of 62 
Years Active: 1992-2017
Title: The Innovative Mind of Alan A. Alfieri
Introduction
Alan A. Alfieri, an accomplished inventor based in Garden City, NY, has made significant contributions in the field of medical treatments, boasting a portfolio of four patents. His pioneering work largely focuses on innovative methods for treating radiation injuries and enhancing cell engraftment techniques.
Latest Patents
One of Alfieri's latest patents is dedicated to stromal cell therapy for the treatment of radiation-induced injury. This patent outlines methods that utilize bone marrow stromal cells expanded in culture, adipose-tissue derived non-adherent stromal cells, or their culture supernatants to mitigate the effects of radiation exposure. Another notable patent details a preparative regimen for the engraftment, growth, and differentiation of non-hematopoietic cells in vivo following transplantation. This invention illustrates how effective administration of specific agents can enhance the proliferation of ex vivo cells at the site of engraftment, ultimately aiming to treat brain injuries through targeted cell engraftment.
Career Highlights
Alan A. Alfieri has been associated with prestigious organizations such as the Sloan Kettering Institute for Cancer Research and Varian Medical Systems, Inc. His work in these institutions has allowed him to explore and develop groundbreaking medical treatments, reflecting his dedication to advancing health care through innovative solutions.
Collaborations
Throughout his career, Alfieri has collaborated with esteemed professionals including Jae H. Kim and Sang H. Kim. These partnerships have bolstered his research efforts and contributed to the successful development of his patented technologies.
Conclusion
Alan A. Alfieri stands out as a visionary inventor making impactful strides in medical science. His contributions not only reflect his expertise but also underscore the importance of innovation in addressing complex health challenges, particularly in the realm of radiation treatment and cell therapy. As research continues to evolve, Alfieri’s work will likely remain at the forefront of medical innovation.